Common Contracts
4 similar Credit Agreement contracts by Icon PLC, PRA Health Sciences, Inc.
THIRD AMENDMENT TO CREDIT AGREEMENTCredit Agreement • April 25th, 2024 • Icon PLC • Services-commercial physical & biological research • New York
This THIRD AMENDMENT to the Credit Agreement referred to below, dated as of March 14, 2024 (this “Third Amendment”), by and among ICON LUXEMBOURG S.À R.L., a société à responsabilité limitée incorporated and existing under Luxembourg law, having its registered office at 61, rue de Rollingergrund, L-2440, Luxembourg and registered with the Luxembourg register of commerce and companies (R.C.S. Luxembourg) under number B66588 (the “Lux Borrower”), ICON CLINICAL INVESTMENTS, LLC, a Delaware limited liability company (the “Lux U.S. Subsidiary Borrower” and, together with the Lux Borrower, the “Lux Term Loan Borrowers”), PRA HEALTH SCIENCES, INC., a Delaware corporation (the “U.S. Borrower”, and collectively with the Lux Term Loan Borrowers, in their capacity as Borrowers of Term Loans, the “Term Loan Borrowers”), ICON CLINICAL RESEARCH LIMITED, a limited liability company incorporated under the laws of Ireland with registration number 201978 and with registered address at South County Busin
FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • February 24th, 2023 • Icon PLC • Services-commercial physical & biological research • New York
CREDIT AGREEMENT, dated as of July 1, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”), among ICON LUXEMBOURG, S.À R.L., a société à responsabilité limitée incorporated and existing under Luxembourg law, having its registered office at 61, rue de Rollingergrund, L-2440, Luxembourg and registered with the Luxembourg register of commerce and companies (R.C.S. Luxembourg) under number B66588 (the “Lux Borrower”), ICON Clinical Investments, LLC, a Delaware limited liability company (the “Lux U.S. Subsidiary Borrower”), INDIGO MERGER SUB, INC., a Delaware corporation (“Merger Sub” and, prior to the consummation of the Acquisition, the “U.S. Borrower”) (which, after giving effect to the Acquisition on the Closing Date, shall be succeeded by PRA Health Sciences, Inc., a Delaware corporation (the “Target” and, following the consummation of the Acquisition, the “U.S. Borrower”), ICON PUBLIC LIMITED COMPANY, an Irish public
CREDIT AGREEMENT dated as of July 1, 2021 among ICON LUXEMBOURG, S.À R.L., INDIGO MERGER SUB, INC., ICON CLINICAL RESEARCH LIMITED, ICON GLOBAL TREASURY UNLIMITED COMPANY, ICON US HOLDINGS INC. and ICON CLINICAL INVESTMENTS, LLC, as Borrowers ICON...Credit Agreement • July 1st, 2021 • Icon PLC • Services-commercial physical & biological research • Delaware
CREDIT AGREEMENT dated as of July 1, 2021 among ICON LUXEMBOURG, S.À R.L., INDIGO MERGER SUB, INC., ICON CLINICAL RESEARCH LIMITED, ICON GLOBAL TREASURY UNLIMITED COMPANY, ICON US HOLDINGS INC. and ICON CLINICAL INVESTMENTS, LLC, as Borrowers ICON...Credit Agreement • July 1st, 2021 • PRA Health Sciences, Inc. • Services-commercial physical & biological research • Delaware
